Below is an English translation of the decision, provided by MLex. The original decision in Chinese can be found here.China’s SAMR conditionally clears Danaher’s acquisition of GE biopharma unitI. ProceduresOn April 29, 2019, China’s State Administration for Market Regulation (SAMR) received a notification of the proposed acquisition by Danaher of the biopharma